Cusatuzumab Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

Cusatuzumab is designed as a first-in-class, high-affinity anti-CD70 monoclonal antibody with multiple intended mechanisms of action, including Fc-mediated cytotoxicity with enhanced ADCC and inhibition of CD70/CD27 signaling, resulting in killing of malignant cells such as leukemia blasts and stem cells.

Cusatuzumab Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Cusatuzumab Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
ShangHai Biochempartner Co.,Ltd	177-54423994 17754423994	2853530910@QQ.com	China	8014	62
Guangzhou Hongyuan Chemical Co.,Ltd	15817493340	981810490@qq.com	China	1565	58
Wuhan Chemstan Biotechnology Co., Ltd.	027-65317797 15926423062	422450190@qq.com	China	10351	58
Biolab Reagents	027-65279366 18162686757	products@biolabreagent.com	China	9818	58
Wuhan Jingkangen Biomedical Technology Co., Ltd	13720134139 13720134139	orders@jknbiochem.com	China	5787	58
Shanghai Yifei Biotechnology Co. , Ltd.	021-65675885 18964387627	customer_service@efebio.com	China	11974	58
Changsha Fuzhen Biotechnology Co.，LTD	13823398779 18670069958	313359644@qq.com	China	3263	58

---

• Cusatuzumab
• Research Grade Cusatuzumab(DHE01901)
• Research Grade Cusatuzumab
• 1399546-01-0